CARY Gains Ground in the U.S. – Test Trials Starting in 2025

Excitus Medical is proud to share that our medical suction device, CARY, is taking a significant step into the U.S. market.

‍
After participating in the Air Medical Transport Conference (AMTC) in Salt Lake City in November 2024, we received incredibly valuable feedback – and the result is clear: CARY will enter test trials with two leading U.S. healthcare providers starting in early 2025.

AMTC is the largest gathering of pre-hospital care providers in the U.S., offering us a unique opportunity to engage with professionals who understand the real challenges in the field. Our goal for the conference was to connect with civilian healthcare organizations and explore the potential for pilot testing – and the response far exceeded our expectations.

Overwhelming Feedback from Industry Professionals

Through demonstrations of CARY’s capabilities, we met with paramedics, physicians, and other experts who all shared a common reaction: CARY is not just another new device – it’s a true solution to critical challenges. Their enthusiasm and recognition mean the world to us as a team that has spent nearly ten years developing this technology.

Launching Pilot Programs with Leading Partners

Following a series of productive meetings during the conference, we are moving forward with test trials in collaboration with:

• Advocate/Atrium Health
• LifeLink III

The trials will begin in 2025, and our manufacturing partner, Innokas Medical Oy, is preparing to deliver the first units of CARY by the end of the year.

A Decade of Development Nearing Reality

This milestone represents a defining moment for all of us at Excitus Medical. After nearly a decade of development, testing, and collaboration, we are finally approaching the moment when our innovation can make a real contribution to global emergency care.

We are grateful, humbled, and excited for what lies ahead in 2025.

‍